Bridge Laboratories closed $18 million in a third round funding, raising the total of VC money raised by the company to $57 million. Bridge said the money will go to expand its Beijing toxicology lab space. Bridge said the money may also be used to make acquisitions, though it did not say whether those companies would be in the US or China. The investors include the previous investors in the Series B round and several new global investors, including Granite Global Ventures (GGV). More details...